baber/WOPTO huggingface dataset:
Patent CA-2379192-A1 (CA)
Title: Systeme de verrouillage de secours pour porte d'inverseur de poussee
Inventor: ROUYER PASCAL GERARD
IPC: F02K1/76
Filed: 2002-03-28
Abstract: Le système de verrouillage de secours de la porte (2) d'un inverseur de poussée comporte une pêne (13) ayant un crochet (12) à profil auto bloquant susceptible d'accrocher une interface de verrouillage (10) de la porte (2) en cas de défaillance des systèmes de verrouillage normaux. Le pêne (13) est sollicité contre l'interface (10) par un ressort (20) disposé dans un vérin dont la tige (34) appuie contre une face frontale d'un talon (22) du pêne terminé par une surface cylindrique (45) de révolution autour de l'axe d'articulation (14) du pêne (13). Lorsqu'on rétracte la tige (34), un levier double (40) déplace positivement le pêne (13) vers une position d'ouverture minimum dans laquelle la porte (2) peut s'ouvrir. Un ressort de déverrouillage (36) provoque l'ouverture totale du pêne lorsqu'un levier d'ouverture (50) est libéré. La tige (34) est en appui sur la surface cylindrique (45) du talon (22) lorsque le pêne (13) est ouvert.  Le ressort (20) est alors inopérant. Le levier d'ouverture (50) est rel ié au pêne (13) par des biellettes (51a, 51b), et limite l'angle d'ouverture du pêne (13).
Patent CA-2380616-A1 (CA)
Title: Process for the biological production of 1,3-propanediol with high titer
Inventor: HAYNIE SHARON
IPC: C12N15/52
Filed: 2000-08-18
Abstract: The present invention provides an improved method for the biological production of 1,3-propanediol from a fermentable carbon source in a single microorganism. In one aspect of the present invention, an improved process for the conversion of glucose to 1,3-propanediol is achieved by the use of an E.  coli transformed with the Klebsiella pneumoniae dha regulon genes dhaR, orfY, dhaT, orfX, orfW, dhaB1, dhaB2, dhaB3, and orfZ, all these genes arranged in the same genetic organization as found in wild type Klebsiella pneumoniae. In another aspect of the present invention, an improved process for the production of 1,3-propanediol from glucose using a recombinant E. coli containing genes encoding a G3PDH, a G3P phosphatase, a dehydratase, and a dehydratase reactivation factor compared to an identical process using a recombinant E. coli containing genes encoding a G3PDH, a G3P phosphatase, a dehydratase, a dehydratase reactivation factor and a 1,3-propanediol oxidoreductase (dhaT). The dramatically improved process relies on the presence in E. Coli of a gene encoding a non-specific catalytic activity sufficient to convert 3-hydroxypropionaldehyde to 1,3-propanediol.
Patent CA-2383253-A1 (CA)
Title: Conditional immortalisation of cells
Inventor: JAT PARMJIT
IPC: A61K35/30
Filed: 2000-09-18
Abstract: A recombinant, or genetically engineered, mammalian cell, comprises a conditionally-inducible oncogene and an exogenous polynucleotide encoding the catalytic sub-unit of the telomerase complex. The recombinant cells are useful in therapy, to replace lost or damaged cells.
Patent CA-2383675-A1 (CA)
Title: Towelette dispensing article
Inventor: OKIN MATTHEW SCOTT
IPC: B65D43/16
Filed: 2002-04-24
Abstract: A dispensing article, particularly for dispensing towelettes, is provided and includes a container body for storing the towelettes and a lid hingedly attached to the body. The container is formed from a floor panel, left and right side panels, front and rear panels. A button flap unitarily formed with the front wall includes a button projecting outwardly from a surface thereof.  The lid includes a latch flap unitarily formed therewith and projecting downward toward the container body. An aperture is formed in the latch flap shaped to receive the button. Latch and button flaps are more flexible than other sections of the lid and container body panels. This flexibility allows for an easy to use, relatively inexpensive locking mechanism and provides good sealing characteristics. A refill canister can be placed within the container body.
Patent CA-2386770-A1 (CA)
Title: Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
Inventor: CAVAZZA CLAUDIO
IPC: A61K36/00
Filed: 2000-10-02
Abstract: A composition is disclosed suitable for the prevention and/or treatment of circulatory disorders at both peripheral and cerebral level, and which can therefore take the form of a dietary supplement, a dietetic support or of an actual medicine, com-prising as characterising active ingredients: (a) a carnitine selected from the group consisting of acetyl L-carnitine and propionyl L-carnitine or a pharmacologically acceptable salt thereof or mixtures thereof; and (b) an extract of Ginkgo biloba or one or more of the ginkgolides isolated from Ginkgo biloba or mixtures thereof.
Patent CA-2387481-A1 (CA)
Title: Reclining motorized multi-position chair with rocking and pivoting action
Inventor: PELLERIN RENE
IPC: A47C3/02
Filed: 2002-05-24
Abstract: A tilt adjustment assembly for a motorized reclining chair having a base frame adapted for rest on a floor surface. A seat and a back articulated support linkage are interconnected together for displacement of a seat and back of a reclining chair. An intermediate frame is mounted on the base frame through spring attachments, whereby to impart a rocking motion to the chair. A pair of foot rest linkages interconnect each of two of the said seat articulated support linkages to a foot rest plate. The tilt adjustment assembly comprises a motor-operated actuating rod secured at a free end to a sliding member to guidingly displace that member along a straight axis in a fixed plane and to any desired position along the axis. A pivotal link arm is pivotally secured at one end of the sliding member.      A transverse linkage securing rod is secured to a second end of the pivotal link arm and extends transversely thereto.      The transverse securing rod has opposed ends pivotally connected to an intermediate link arm of a respective one of the pair of foot rest linkages. Tensioning springs are secured to each of the pair of foot rest linkages for applying a restoring force to the foot rest to a retracted position.
Patent CA-2387822-A1 (CA)
Title: Fibers from plant seeds and use
Inventor: MCDONALD JOHN T
IPC: A23L13/40
Filed: 2000-10-13
Abstract: The disclosed provides a process of modifying a seed based fiber (SBF) to form an enhanced fiber additive (EFA).  The process includes an acid treatment step and optionally at least one fiber modification step. Preferred EFA products and uses are described.
Patent CA-2390504-A1 (CA)
Title: Cytochrome p450 oxygenases and their uses
Inventor: SCHOENDORF ANNE
IPC: C12P17/02
Filed: 2000-11-13
Abstract: Oxygenase enzymes and the use of such enzymes to produce paclitaxel (TaxolTM ), related taxoids, as well as intermediates in the Taxol biosynthetic pathway are disclosed. Also disclosed are nucleic acid sequences encoding the oxygenase enzymes.
Patent CA-2391253-A1 (CA)
Inventor: CAYER CHRISTOPHER GEORGE
IPC: G09F15/00
Filed: 2002-06-25
Abstract: A collapsible upright display unit is provided that can easily be disassembled and transported. It involves a display sheet and parabolic support members which are joined by disconnectable connecting means to both tension the display sheet and act as a stand to hold the display sheet upright.
Patent CA-2398828-A1 (CA)
Title: A pharmaceutical composition containing an indolopyrrolocarbazole derivative
Inventor: BRESLIN DAVID T
IPC: A61K47/02
Filed: 2002-08-20
Abstract: The present invention is directed to a pharmaceutical composition comprising a compound of Formula I dissolved in propylene glycol and water.  The present invention also relates to a pharmaceutical composition containing a compound of Formula I dissolved in propylene glycol and a buffer that has a pH between about 3 and about 5
Patent CA-2399432-A1 (CA)
Inventor: KUFE DONALD W
IPC: A61K35/12
Filed: 2001-02-12
Abstract: Methods of generating CTL using fused cells formed by fusions between dendritic cells and non-dendritic cells (e.g., cancer cells), CTL generated by these methods, methods of treatment involving administering the CTL to mammalian subjects, methods of identifying peptides recognized by the CTL, and methods of inducing immune response in mammalian subjects involving administration of the identified peptides, or polypeptide antigens of which the peptides are fragments, to the mammals.
Patent CA-2400202-A1 (CA)
Title: Polyester tackifier and adhesive composition
Inventor: HAZEN JOHN
IPC: C09J167/00
Filed: 2001-02-09
Abstract: The invention relates to a novel polyester tackifier, adhesive compositions comprising the tackifier and methods of preparation. More specifically, the polyester tackifier is obtainable by polymerising a mixture comprising a diacid or derivative thereof, a diol, and at least 6 molar % of an organic monofunctional compound, wherein the mixture is essentially free from com-pounds comprising more than two carboxylic acid groups or alcohol groups.
Patent CA-2402589-A1 (CA)
Inventor: ZANEVELD LOURENS JAN DIRK
IPC: A61K47/12
Filed: 2001-03-06
Abstract: Antimicrobial and contraceptive compositions and methods which prevent and/or reduce the risk of transmission of sexually transmitted diseases through sexual activity as well as prevent and/or reduce the risk of pregnancy are provided. The compo-sitions contain (1) a matrix-forming agent, (2) a bio-adhesive agent, (3) a buffering agent, (4) optionally a humectant, (5) optionally a preservative, and (6) water; wherein the composition is suitable for application within the vagina; wherein the compositions form a semisolid matrix on contact with ejaculate (thereby trapping ejaculated microbes and spermatozoa); wherein the composition causes hardening of cervical mucus (thereby decreasing the probability of sperm entry); wherein the composition forms a bio-adhesive layer over vaginal surfaces (thereby preventing or reducing the risk of contact of STD-causing microbes with the vaginal surfaces);  wherein the composition maintains an acidic vaginal pH of less than about 5 in the presence of semen ejaculated from the male; and wherein the composition does not significantly impair the natural microbiological balance within the vagina. The antimicrobial and contraceptive compositions may also contain additional antimicrobial and/or contraceptive agents (e.g., nonoxynol-9, octoxynol-9, benzalkonium chloride, phosphorylated hesperidins, sulfonated hesperidins, polystyrene sulfonates, substituted benzenesulfonic acid formaldehyde co-polymers, H2SO4-modified mandelic acids, povidone iodine, itraconazole, ketoconazole, metronidazole, clotrima-zole, fluconazole, teraconazole, miconazole, tinidazole, iconazole, chloramphenicol, nystatin, cyclopiroxolamine, and the like).
Patent CA-2407038-A1 (CA)
Title: Lentilles de contact fluorescentes
Inventor: QUINN MICHAEL H
IPC: G02C7/04
Filed: 2001-03-27
Abstract: Cette invention concerne une lentille de contact dans laquelle est dispersé au moins un colorant fluorescent, ou bien une lentille de contact qui renferme au moins un colorant classique et au moins un colorant fluorescent. L'invention porte également sur des procédés de fabrication et d'inspection des lentilles de contact.
Patent CA-2408071-A1 (CA)
Title: Ring fixator
Inventor: ROSSI GRAZIANO
IPC: A61B17/62
Filed: 2001-05-08
Abstract: The invention relates to an external fixator apparatus (1) of the ring type for stabilizing bone fractures, comprising at least one pair of rings (6, 7), of which one (6) is proximal and the other (7) is distal, and at least one tie rod (8, 9, 10) interconnecting the rings (6, 7) to each other, wherein the rod (8, 9, 10) is split into two rod sections (11, 12) connected together by a joint (21) and the joint (21) comprises a pivot mount (22) having a predetermined axis (x-x) for the angular displacement of the rod sections (11, 12), and comprises a sliding mount (23) according to a predetermined sliding direction (y-y) for offsetting the rod sections (11, 12).
Patent CA-2408841-A1 (CA)
Inventor: LASSMANN WALTER
IPC: C09D5/00
Filed: 2001-06-12
Abstract: The invention relates to the use of a copolymer (A) which can be produced by radical polymerisation of a) at least one olefinically unsaturated monomer and b) at least one olefinically unsaturated monomer of general formula (I) R1R2C=CR3R4 which is different from said olefinically unsaturated monomer (a), the radicals R1, R2, R3 and R4 each representing, independently of each other, hydrogen atoms or substituted or unsubstituted alkyl-, cycloalkyl-, alkylcycloalkyl-, cycloalkylalkyl-, aryl-, alkylaryl-, cycloalkylaryl-arylalkyl- or arylcycloalkyl radicals, on the condition that at least two of the variables R1, R2, R3 and R4 represent substituted or unsubstituted aryl-, arylalkyl- or arylcycloalkyl radicals, especially substituted or unsubstituted aryl radicals; in an aqueous medium, for producing deformable laminates or coating films for imparting a colour and/or effect.
Patent CA-2414783-A1 (CA)
Title: Treatment of eating disorders using carboxyalkylethers
Inventor: BUTLER DONALD EUGENE
IPC: A61P3/04
Filed: 2001-05-18
Abstract: arboxyalkylethers are useful for treating eating disorders such as obesity.< /SDOAB>
Patent CA-2417521-A1 (CA)
Inventor: STERN ROGER A
IPC: H04R1/02
Filed: 1996-10-31
Abstract: An ultrasound transducer device is disclosed which is intended to be used for continuous imaging of a patient's heart or other body organs for diagnosis or monitoring. The device consists of a spherical transducer assembly held by a patch which is coated with adhesive for attaching to the body surface of a patient. Provision is made for the manual adjustment of the orientation of the transducer assembly while in place on a patient to adjust the area scanned by the transducer. An alternate embodiment of the device discloses provision for remote controlled adjustment of the transducer assembly orientation.
Patent CA-2420717-A1 (CA)
Title: Artificial intelligence system for genetic analysis
Inventor: OSBORNE GLENN F
IPC: G16B25/00
Filed: 2000-08-28
Abstract: The present invention provides a complete artificial intelligence system for  the acquisition and analysis of nucleic acid array hybridization information . The system is divided into at least one central data processing facility and  one or more user facilities, linked by encrypted network connections or similar links. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing  system to convert the optical data into a set of hybridization parameters, a  connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a  gene chip or DNA microarray, or a proteomics chip, analyzes test results bas ed on maintained parameters, evaluates patient risk for various ailments, recommends methods of treatment, presents information to medical and/or private individuals, and notifies test participants when new treatment becom es available.
Patent CA-2421091-A1 (CA)
Inventor: GUTIERREZ NOVELO MANUEL RAFAEL
IPC: H04N13/239
Filed: 2001-03-13
Abstract: L'invention concerne un système de caméra vidéo, de codage, de transmission, de décodage et de présentation d'images en trois dimensions utilisé dans un but quelconque au moyen d'une technologie stéréoscopique mise en oeuvre au moyen de deux nouveaux dispositifs électroniques, d'un dispositif de caméra vidéo trois dimensions et d'un dispositif qui décode ces signaux et les présente à l'utilisateur final sur deux écrans couleur à cristaux liquides, donnant ainsi un effet de profondeur et de distance entre les objets transmis à distance par rapport à l'utilisateur final. L'invention a pour objectif de générer un nouveau type de transmission en trois dimensions qui est totalement différent des moyens actuels et qui est le résultat de l'intégration stéréoscopique de technologie, de connaissances technologiques en optique et dans autres domaines, tout en utilisant l'infrastructure actuelle des stations de télévision et de diffusion. La conception innovatrice de ce produit permettra à l'être humain de changer radicalement sa manière de communiquer ainsi que la forme dans laquelle il recevra des images.
Patent CA-2421170-A1 (CA)
Title: Reversible petri dish
Inventor: HALL JOHN P
IPC: C12M1/22
Filed: 2003-03-05
Abstract: A reversible Petri dish having selectable structural features for different applications related to receiving, growing and examining biological entities is provided.  The reversible dish can be flipped over to select the dish side having the desired structural features. The reversible dish can accommodate uses which require the entire surface area of the bottom of a dish on one side and which require a deeper volume over less surface area on the opposite side.
Patent CA-2421966-A1 (CA)
Inventor: TAMURA MASAHIKO
IPC: A61K47/26
Filed: 2001-09-13
Abstract: L'invention concerne des remèdes efficaces contre des maladies ischémiques comprenant le facteur de stimulation des colonies de granulocytes (hG-CSF) en tant qu'agent actif, ainsi qu'un procédé efficace permettant de surmonter les problèmes survenant spécifiquement lors de kinésithérapie, pharmacothérapie et revascularisation conventionnelles, et lors de thérapie génique et transplantation intramusculaire de cellules de moelle osseuse proposées plus récemment pour l'artériosclérose oblitérante, par administration des remèdes susmentionnés. Ces remèdes peuvent également être utilisés comme remèdes pour des maladies ischémiques telles que des maladies ischémiques cérébro-vasculaires et des cardiopathies ischémiques.
Patent CA-2424013-A1 (CA)
Inventor: CARLSON ROBERT M
IPC: A61K31/56
Filed: 2001-10-01
Abstract: Methods of treating a fungal or yeast infection and of killing or inhibiting fungi or yeast are disclosed. The methods use derivatives of triterpenes that are abundant in birch bark and other plants. The triterpenes include betulin, allobetulin, and lupeol.
Patent CA-2424070-A1 (CA)
Title: Method of railroad rail repair
Inventor: VALLEY GREG A
IPC: E01B29/44
Filed: 2001-09-27
Abstract: A method of repairing a damaged railroad rail (1) comprising the steps of:  identifying a defect in the rail (1), removing the portion of the rail (1) having a defect and leaving two truncated rail ends (31, 32), preparing the truncated rail ends (31, 32) for welding, and welding the two truncated rail ends (31, 32) together.
Patent CA-2424126-A1 (CA)
Title: Toy airplane powered by electric motor and capacitor power source
Inventor: BARTHOLD MARK
IPC: A63H27/14
Filed: 2002-01-17
Abstract: A toy airplane (10) includes a flying wing body (11) having a capacitor- powered electric motor propulsion apparatus supported within the body. A charging receptacle (13) is formed in the airplane body (11) and supports electrical contacts, which in turn are coupled to the propulsion unit. A separate battery-powered charger (50) includes a charger head (56) insertabl e into the receptacle to transfer energy from internal batteries within the charger (50) to the capacitor power unit of the airplane. A launcher button (24) operates normally closed switch to decouple the motor from the propulsi on unit during the charging process.
Patent CA-2424228-A1 (CA)
Title: Method and apparatus for integrated horizontal selective testing of wells
Inventor: HOOK PETER F
IPC: E21B47/10
Filed: 2003-03-31
Abstract: Integrated horizontal selective testing of production flow from individual perforations or individual lateral branches of a highly deviated or horizontal multilateral branch well is accomplished by a downhole flow rate testing tool which is selectively positioned within the wellbore by a coiled tubing deployment system for multiple downhole production flow rate tests to indicate the production flow rates of individual lateral branches or perforated zones. Logging tools are on-board the downhole flow rate testing tool for accuracy of tool location and for conducting downhole production flow rate tests. A multi-phase flowmeter at the surface measures the total production flow rate of fluid flowing in the flowline of the well. Real-time downhole flow measurements are correlated to provide a production flow rate profile. The well operator may take remedial action using on-site equipment if the tests show excessive water or gas from any lateral branch.
Patent CA-2426148-A1 (CA)
Inventor: UCKUN FATIH M
IPC: A61P31/18
Filed: 2000-10-19
Abstract: Novel aromatic and heterocyclic thiazolyl thiourea compounds, of the formula I  and II and pharmaceutical compositions including such, and methods for their use are disclosed. The compounds are effective agents for the treatment of HIV  infection, including non-nucleoside inhibitor-resistant, and multi-drug resistant strains of HIV.
Patent CA-2426593-A1 (CA)
Title: Ketolide antibacterials
Inventor: HLASTA DENNIS
IPC: A61P31/04
Filed: 2001-10-12
Abstract: The present invention includes compounds of the formula wherein: X is hydrogen or halide; R2 is hydrogen, acyl, or a hydroxy protecting group; R6 is hydrogen, hydroxyl, or -ORa wherein Ra is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl; R13 is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and, R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.
Patent CA-2427659-A1 (CA)
Inventor: HUSE WILLIAM D
IPC: A61K39/395
Filed: 2001-10-30
Abstract: The invention provides a binding polypeptide, or functional fragment thereof, comprising a kon of at least about 9 x 107 M-1 s-1 for associating with a ligand and having therapeutic potency. The invention also provides a method of determining the therapeutic potency of a binding polypeptide. The methods consist of (a) contacting a binding polypeptide with a ligand; (b) measuring association rate for binding between the binding polypeptide and the ligand, and (c) comparing the association rate for the binding polypeptide to an association rate for a therapeutic control, the relative association rate for the binding polypeptide compared to the association rate for the therapeutic control indicating that the binding polypeptide wil exhibit a difference in therapeutic potency correlative with the difference between the association rates.